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P R E V I E W STo be or NUCB2, is nesfatin the answer?
Signals from the hypothalamus govern food intake and energy balance. A new study describes nesfatin-1, a hypothalamic
and brainstem peptide whose expression decreases during fasting. Although central treatment with nesfatin-1 inhibited
food intake and nesfatin-1 blockade increased food intake, the role and mechanism of nesfatin in energy balance remains
unclear.Doesanyhomeostatic system in thebody
operate in isolation? The (hopefully self-
evident) answer is ‘‘No.’’ Homeostatic
processes are highly complex and inte-
grated and require constant adjustment
of the gain andoffset. The recent descrip-
tion of the isolation of a hypothalamic
peptide nesfatin (Oh-I et al., 2006), which
seems to modulate food intake, prompts
us to examine how new peptides are
pigeonholed as cogs in these complex
physiological systems.
Oh-I and colleagues demonstrate
comprehensively the function of a new
peptide isolated from a series of screens.
They used a subtraction cloning strategy
to isolate genes regulated by a peroxi-
some proliferator-activated receptor g
agonist (troglitazone) in a lung cell line
and specifically searched signal pep-
tide-bearing genes that were also ex-
pressed in neural and fat cell lines.
NUCB2, a 396 aa peptide, is highly con-
served between humans and rodents,
andmRNA and immunoreactive cell bod-
ies can be found in several hypothalamic
nuclei; however, only the paraventricular
nucleus expression was decreased by
fasting.NUCB2has several sites for post-
translational cleavage by prohormone
convertases, and intracerebroventricular
(i.c.v.) injection of NUCB2 or its first
82 amino acids (termed nesfatin-1 for
NEFA/nucleobindin2-encoded satiety
factor) acutely, transiently, and dose-
dependently inhibited dark phase food
intake in rats. Other posttranslational
products of NUCB2, or a NUCB2 mutant
that cannot be cleaved at aa 82–83, did
not inhibit food intake. These NUCB2
fragments (termed nesfatin-2 and -3)
have structures similar to that of DNA or
calcium binding proteins.
I.c.v. injection of antiserum to nesfatin-
1 increased food intake, suggesting that
an endogenous tone of nesfatin restrains
food intake. This finding is important in
building a case for a physiological role
for this peptide in the regulation of appe-
tite; it also suggests that agonists of this
system may be useful for obesity thera-CELL METABOLISM : DECEMBER 2006peutics. Indeed, subchronic i.c.v. infu-
sion of nesfatin-1 resulted in decreased
food intake, body weight gain, and fat
pad weights. Conversely, downregula-
tion of the mRNA for NUCB2 with i.c.v.
antisense oligonucleotides increased
food intake and body weight gain. These
increases in food intake and weight gain
present the most persuasive evidence of
a physiological role for nesfatin-1 in en-
ergy balance. However, many things
can nonspecifically inhibit eating in ani-
mals—i.e., illness, thirst, and sleep. Sim-
ply increasing food intake in laboratory
rodents does not tell us the specific role
that a neuropeptide may play in the regu-
lation of energy balance. For example,
orexin can stimulate food intake in certain
models, yet it is not currently considered
to be a primary driver of appetite.
Many neuropeptide systems are in-
volved in the regulation of food intake
and energy balance, and the leptin and
melanocortin signaling systems are of-
ten placed in the center of this complex
circuitry. Oh-I and colleagues use several
established tools to characterize the im-
portance of nesfatin-1 in these contexts.
Nesfatin-1 was equally effective at inhib-
iting food intake in lean and Zucker fatty
(leptin receptor mutant) rats, which is
not surprising given that nesfatin’s ex-
pression in the brain puts it likely down-
stream of leptin. Furthermore, nesfatin
antiserum did not change the acute an-
orexic effect of i.c.v. leptin, indicating
that nesfatin is not critical for leptin’s
action in the brain. Central injection
of a-MSH stimulated the expression of
NUCB2 in the PVH, which parallels the
increased NUCB2 expression after 24 hr
fast, suggesting that nesfatin neurons in
the PVH may be a downstream target
for melanocortin neurons and may be
directly regulated by melanocortins
(Figure 1). However, themelanocortin an-
tagonist SHU9119 prevented nesfatin-1
induced anorexia, which may indicate
that the two systems interact at a com-
mon terminal field. Unfortunately, these
final studies provide limited insight as tohow nesfatin-1 acts to regulate energy
balance. Itmaybepremature to conclude
that nesfatin-1 acts through amelanocor-
tin pathway to regulate energy balance.
Additional clues to the roles of nesfatin-
1might come from in vivo studies, aiming
to determine the exact components of
fasting that regulate NUCB2 expres-
sion—i.e. glucopenia, hypoinsulinemia,
or stress. It is also reasonable to expect
that molecular genetic approaches could
be applied to the question of nesfatin-1
function. Furthermore, comprehensive
neuroanatomical studies are needed to
understand the interaction of nesfatin
neurons (from the different neuronal pop-
ulations) within the complex circuitry that
has already been described.
Significant caveats should be applied
to interpretations of antibody staining
(Rhodes and Trimmer, 2006), and in par-
ticular, it should be remembered that pre-
venting staining by presorbing with the
antigen only proves that the antiserum is
reacting to the antigen and does not rule
out that it also binds to something else.
Oh-I and colleagues do provide multiple
convergent data sets that all point to nes-
fatin-1 playing a role in energy balance.
The exact role, however, remains elusive.
Fasting decreased NUCB2 mRNA ex-
pression only in the PVH (not in the other
sites of expression) and decreased nes-
fatin-1 protein expression in the PVH.
Therefore, the regulation of NUCB2 ex-
pression and activity is complex, involv-
ingmore than justmelanocortin peptides.
The question asked can determine the
answer. While attributing a single role to
a newmolecule or pathway is a very help-
ful pedagogic tool, recent literature has
some cautionary examples of overeager
attribution of function. It is quite clear
that orexin (Sakurai et al., 1998) and obe-
statin (Zhang et al., 2005) exist. Their
usual function, however, may bear little
relationship to their names. Indeed, their
roles in the regulation of food intake may
only be oblique. Follow-up studies have
uncovered other functions for these
peptides—orexin seems to be implicated421
P R E V I E W SFigure 1. Schematic of possible NUCB2 neuronal pathways
NUCB2 expressing neurons (green) are found in several regions of the brain. Some neurons in the parvocellular
PVH (pPVH) express NUCB2 and the melanocortin receptor (MC4) and receive input from a-MSH and AgRP
fibers. a-MSH increases the expression and release of nesfatin-1. Oh-I and colleagues (2006) propose that
NUCB2 neurons in the pPVH cause anorexia by secretion of nesfatin-1, although the site of action of nesfa-
tin-1 remains unknown. Fasting causes changes in levels of peripheral metabolic signals (i.e., leptin and ghre-
lin), which act through the arcuate nucleus (ARH) to decrease the activity of POMC neurons (dark blue) and
increase the activity of AgRP neurons (light blue). Oh-I and colleagues propose that fasting decreases activity
of pPVH NUCB2 neurons via a melanocortin dependent pathway. Several other pathways also deserve con-
sideration. Stress also causes anorexia, and it may do so by activating NUCB2 neurons in the pPVH. Magno-
cellular neurons in the supraoptic nucleus (SON) and PVH (mPVH) are known to project to the posterior
pituitary and regulate fluid balance. NUCB2 neurons in these regions may indirectly affect food intake by
changing fluid balance. Surprisingly, NUCB2 neurons in the mPVH, SON, ARH, lateral hypothalamus/zona
incerta (LHA/ZI), and nucleus of the solitary tract (NTS) were not affected by fasting or melanocortins, and thus
their functions remain unclear.in control of arousal (Siegel, 1999) and in
regulation of mesolimbic pathways that
contribute to coding of importance and
attention (Harris et al., 2005). Obestatin
was originally described as an anorexi-
gen (Zhang et al., 2005), yet more recent
data suggest it may actually inhibit fluid422intake (Samson et al., 2006), which can
then secondarily decrease food intake
(Watts, 1999).
Nesfatin neurons were found in several
hypothalamic regions and within the
brainstem, with only the PVH neurons
being affected by fasting. Fasting is apotent stressor, and the PVH is critical
for integrating stress signals. The expres-
sion of nesfatin-1 in the magnocellular
zone of the PVH and in the supraoptic
nucleus might additionally argue for an
effect on thirst. Work by Samson and
coworkers shows how effects on fluid
intake can conflated as effects on food
intake (Samson et al., 2006); we might
propose a similar scheme for nesfatin-1,
although this speculation remains un-
tested (Figure 1). Implicit in this hypothet-
ical schematic is the unknown role of
the non-PVH populations of nesfatin-1
neurons. Many questions remain to be
answered before this neuropeptide can
be considered a critical regulator of
food intake and energy balance.
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